A Study in Healthy Volunteers to Evaluate Serum and Urine Levels of the Investigational Product Versus Comparator.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00280358

Enrollment

Registered

2006-01-23

Start date

Unknown

Completion date

2005-12-31

Last updated

2008-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Fluticasone, Formoterol, PK Study, Pharmacokinetics

Brief summary

The purpose of the study is to obtain initial pharmacokinetic data in healthy patients after dosing a combination of the study medications.

Interventions

DRUGFluticasone Propionate

DRUGFormoterol Fumarate

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

* Non-smokers, BMI 18-29, no current medications

Exclusion criteria

* Significant conditions or disease

Design outcomes

Primary

Measure	Time frame
Levels of study medication in blood and urine.	—

Secondary

Measure	Time frame
Safety/tolerability	—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026